Circulating biomarkers for diagnosis, prognosis and treatment response prediction in cancer - Part A - Galluzzi, Lorenzo; Spada, Sheila; (ed.) - Prospero Internet Bookshop
Basket (0)
Wishlist (0)
Your personal newsletter
__

Circulating biomarkers for diagnosis, prognosis and treatment response prediction in cancer - Part A
 
Product details:
ISBN13:9780443345296
ISBN10:0443345295
Binding:Hardback
No. of pages:274 pages
Size:228x152 mm
Weight:450 g
Language:English
700
Category:

Circulating biomarkers for diagnosis, prognosis and treatment response prediction in cancer - Part A

 
Publisher: Academic Press
Date of Publication:
 
Normal price:
Publisher's listprice:
EUR 171.00
Estimated price in HUF:
72 538 HUF (69 084 HUF + 5% VAT)
Why estimated?
 
Your price:
65 284 (62 176 HUF + 5% VAT )
discount is: 10% (approx 7 254 HUF off)
The discount is only available for 'Alert of Favourite Topics' newsletter recipients.
Click here to subscribe.
 
Availability:
Not yet published.
 
Add to basket
  Piece(s)

 
Long description:
Circulating Biomarkers for Diagnosis, Prognosis and Treatment Response Prediction in Cancer Patients, Part A, Volume 391 delves into the crucial role of circulating biomarkers in cancer diagnosis and treatment monitoring. Specific chapters in this new release include Circulating biomarkers for diagnosis and response to therapies in cancer patients, Identification of circulating tumor DNA as a biomarker for diagnosis and response to therapies in cancer patients, Identification of cell-free circulating epigenomic biomarkers for early diagnosis and response to therapies in breast cancer patients, Expanding frontiers in liquid biopsy-discovery and validation of circulating biomarkers in renal cell carcinoma and bladder cancer, and much more.

This comprehensive work explores the various types of biomarkers, their significance in early cancer detection, prognostication, and evaluation of therapeutic responses. It covers cutting-edge research on circulating tumor cells, cell-free DNA, exosomes, and other biomarkers that can revolutionize cancer management. Additionally, it discusses the challenges, advancements, and future prospects of utilizing circulating biomarkers in personalized cancer care.
Table of Contents:

Preface
Sheila Spada and Lorenzo Galluzzi
1. Circulating biomarkers for diagnosis and response to therapies in cancer patients
Natália Marcéli Stefanes, Maria Eduarda Cunha-Silva, Lisandra de Oliveira Silva,
Laura Otto Walter, Maria Cláudia Santos-Silva, and Manas Ranjan Gartia
2. Identification of circulating tumor DNA as a biomarker for diagnosis and response to therapies in cancer patients
Ronan W. Hsieh, Lynn K. Symonds, Jason Siu, and Stacey A. Cohen
3. Identification of cell-free circulating epigenomic biomarkers for early diagnosis and response to therapies in breast cancer patients
Pooja Ratre, Suresh Thareja, Pradyumna Kumar Mishra
4. Expanding frontiers in liquid biopsy-discovery and validation of circulating biomarkers in renal cell carcinoma and bladder cancer
Sabareeswaran Krishnan, Shruthi Kanthaje, Punchappady Devasya Rekha,
M. Mujeeburahiman, and Chandrahas Koumar Ratnacaram
5. Interleukin 10: Bridging the chasms in the immune landscape of multiple myeloma
Queenie Fernandes, Abdul W. Ansari, Karama Makni-Maalej, Maysaloun Merhi,
Said Dermime, Aamir Ahmad, and Shahab Uddin
6. Nectin-4: A promising prognostic marker and therapeutic target in cancer
Shilpa Kuttikrishnan, Kirti S. Prabhu, Ummu Habeeba, Zahwa Mariyam, Queenie Fernandes, Mohsin Maqbool, Omar M. Khan, Ajaz A. Bhat, and Shahab Uddi